lystn

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.naceonline.com/courses/using-natriuretic-peptides-effectively-in-heart-failure-podcast?client=
 
Featuring James L. Januzzi, MD, FACC, FESC as faculty, moderated by Gregg Sherman, MD.

This course will review natriuretic peptide (NP) testing, based on guideline recommendations, to diagnose heart failure (HF), including patients in high-risk populations, such as those with diabetes mellitus or hypertension. In addition, the course will cover NP testing for prognostication in patients with established HF, or at risk for HF, including those with existing comorbidities such as diabetes mellitus or hypertension, as part of their overall disease monitoring and pharmacotherapeutic management.  

Originally limited to the diagnosis of acute heart failure (HF) in the emergency room, natriuretic peptides (NPs) are now considered valuable markers that can be useful in the screening, diagnosis, prognostication, and monitoring of patients with HF. NP testing can be used to rule out HF in patients presenting with acute or chronic dyspnea, for prognostication in patients diagnosed with HF, and to guide therapy for chronic HF patients. As primary care clinicians play a crucial role in the early recognition and ongoing monitoring of patients with HF, it is important that they be familiar with the role of NPs in HF and with current recommendations regarding NP testing for screening, diagnosis, prognostication, and monitoring in HF in order to improve patient care and outcomes.

This activity is accredited for CME/CE credit.
 
 For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.naceonline.com/courses/using-natriuretic-peptides-effectively-in-heart-failure-podcast?client=

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 contact hour (which includes 0 hours of pharmacology).

This educational activity is supported by an educational grant from Roche Diagnostics Corporation.